Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(6-methoxy-napthalen-2-yl)-propionic Acid 4-thiocarbamoyl-phenyl Ester
2. Atb-346
1. 1226895-20-0
2. Atb-346
3. Atb 346
4. Otenaproxesul
5. (s)-atb-346
6. 3096o7wp53
7. (4-carbamothioylphenyl) 2-(6-methoxynaphthalen-2-yl)propanoate
8. 2-naphthaleneacetic Acid, 6-methoxy-alpha-methyl-, 4-(aminothioxomethyl)phenyl Ester
9. Atb346
10. 4-carbamothioylphenyl 2-(6-methoxynaphthalen-2-yl)propanoate.
11. Unii-3096o7wp53
12. Abt-346
13. Schembl2883303
14. Chembl4211107
15. Otenaproxesul, (+/-)-
16. Dtxsid201336751
17. Bcp09624
18. Bzb89520
19. Ex-a1790
20. Mfcd19443776
21. Akos025405101
22. Db15377
23. Sb16824
24. Ncgc00386745-04
25. Ac-35902
26. Da-35319
27. Hy-15028
28. B3584
29. Ft-0706066
30. S6615
31. Q27255936
32. 4-(aminocarbothioyl)phenyl 2-(6-methoxy-2-naphthyl)propanoate
33. 4-thiocarbamoylphenyl 2-(2-methoxynaphthalen-6-yl)propanoate
34. 2-(6-methoxy-napthalen-2-yl)-propionic Acid 4-thiocarbamoyl-phenyl Ester
35. 2-naphthaleneacetic Acid, 6-methoxy-.alpha.-methyl-, 4-(aminothioxomethyl)phenyl Ester
| Molecular Weight | 365.4 g/mol |
|---|---|
| Molecular Formula | C21H19NO3S |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 365.10856464 g/mol |
| Monoisotopic Mass | 365.10856464 g/mol |
| Topological Polar Surface Area | 93.6 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 504 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Otenaproxesul manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Otenaproxesul, including repackagers and relabelers. The FDA regulates Otenaproxesul manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Otenaproxesul API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Otenaproxesul supplier is an individual or a company that provides Otenaproxesul active pharmaceutical ingredient (API) or Otenaproxesul finished formulations upon request. The Otenaproxesul suppliers may include Otenaproxesul API manufacturers, exporters, distributors and traders.
Otenaproxesul Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Otenaproxesul GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Otenaproxesul GMP manufacturer or Otenaproxesul GMP API supplier for your needs.
A Otenaproxesul CoA (Certificate of Analysis) is a formal document that attests to Otenaproxesul's compliance with Otenaproxesul specifications and serves as a tool for batch-level quality control.
Otenaproxesul CoA mostly includes findings from lab analyses of a specific batch. For each Otenaproxesul CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Otenaproxesul may be tested according to a variety of international standards, such as European Pharmacopoeia (Otenaproxesul EP), Otenaproxesul JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Otenaproxesul USP).
LOOKING FOR A SUPPLIER?
